Oculyra - Florrax Pharmaceutical
- Manufacturer
- Florrax Pharmaceutical
- Effective date
- 2026-09-11
- Label type
- DIETARY SUPPLEMENT
- Version
- 1
- Source
- daily-update
- Hydrated at
- 2026-09-16 01:01:07
Label at a glance#
Label contents#
Full prescribing information#
Description:
Oculyra Eye-Health Nutritional Supplement Tablets are orally administered tablets dispensed in plastic bottles of 30 count.
84460-0951-30
Reserved for Professional Recommendation
Oculyra Eye-Health Nutritional Supplement Tablets should be administered under the supervision of a licensed medical practitioner.
Oculyra is an orally administered eye-health nutritional supplement formulation containing vitamins, minerals, carotenoids, antioxidants, botanical extracts, and algal DHA. The formulation is intended to provide nutritional support for eye health and to supplement dietary intake where advanced nutritional supplementation is recommended.
This listed product is not a National Drug Code, but instead has merely been formatted to comply with standard industry practice for pharmacy and insurance computer systems.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
All recommendations or prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. This product may be administered only under the supervision of a licensed healthcare practitioner. There are no implied or explicit claims of therapeutic equivalence.
Manufactured for: Florrax Pharmaceutical, Dallas, TX.
Warnings:
This product is contraindicated in individuals with a known hypersensitivity to any of the ingredients contained in Oculyra.
Oculyra should be used under the direction and supervision of a licensed healthcare practitioner. Consult a licensed healthcare practitioner before use if you have a medical condition, are pregnant or lactating, are trying to conceive, are under 18 years of age, or are taking prescription or over-the-counter medications or other dietary supplements.
Do not exceed the recommended dosage unless directed by a licensed healthcare practitioner.
Keep out of reach of children. Do not use if the safety seal is broken or missing.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Dosage:
Take two (2) tablets daily, or as directed by a licensed healthcare practitioner.
Oculyra is intended for oral administration. Do not exceed the recommended dosage unless otherwise directed by a licensed healthcare practitioner.
Packaging:
CONTRAINDICATIONS
Oculyra is contraindicated in individuals with a known hypersensitivity to any of the ingredients contained in the formulation.
PRECAUTIONS
Oculyra should be used under the direction and supervision of a licensed healthcare practitioner. Consult a licensed healthcare practitioner before use if you have a medical condition, are pregnant or lactating, are trying to conceive, are under 18 years of age, or are taking medications or other dietary supplements.
Do not exceed the recommended dosage unless otherwise directed by a licensed healthcare practitioner.
ADVERSE REACTIONS
Individuals sensitive to any ingredient in Oculyra may experience an allergic or hypersensitivity reaction. Discontinue use and consult a licensed healthcare practitioner if an adverse reaction occurs.
KEEP OUT OF THE REACH OF CHILDREN.
Storage:
Store at 20° - 25° C (68° - 77° F); excursions permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature]
Packaging:
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0385477000228 | GTIN-13: 0385477000228 EAN-13: 0385477000228 GTIN-12: 385477000228 UPC-A: 385477000228 GTIN storage (14 digits): 00385477000228 | oculyra-2.jpg |
Products#
Every source-derived product name is available through these pages.
- Oculyra
- ASCORBIC ACID
- CHOLECALCIFEROL
- .ALPHA.-TOCOPHEROL ACETATE, D-
- .ALPHA.-TOCOPHEROL, D-
- FOLIC ACID
- METHYLCOBALAMIN
- ZINC
- COPPER
- MAGNESIUM GLYCINATE
- MAGNESIUM CATION
- LUTEIN
- ZEAXANTHIN
- ZEAXANTHIN, MESO-
- ASTAXANTHIN
- SCHIZOCHYTRIUM DHA OIL
- BILBERRY
- SAFFRON
- ACETYLCYSTEINE
- ALPHA LIPOIC ACID
- MICROCRYSTALLINE CELLULOSE
- CROSCARMELLOSE SODIUM
- MAGNESIUM STEARATE
- HYPROMELLOSE 2208 (100 MPA.S)
- SILICON DIOXIDE
- TITANIUM DIOXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 84460-951 | 84460-951-30 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ascorbic Acid | ASCORBIC ACID | Renova Pharmaceuticals LLC | a6481bae-2397-44c7-a51d-4f47ad91bd2c | 2026-08-19 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascor | ASCORBIC ACID | McGuff Pharmaceuticals, Inc. | 388aad52-fc01-4784-9791-1dbc80c69306 | 2026-05-29 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascorbic Acid | ASCORBIC ACID | Fresenius Kabi USA, LLC | 1606e29f-0e80-4069-b688-daab9cbff20a | 2025-12-17 | Warnings, Adverse reactions | ASCORBIC ACID |
| Skin Renewing Serum | ASCORBIC ACID | Guangzhou Danting Bath&Body Care Industry Co. Ltd | 396c2a8d-ac95-cbef-e063-6294a90aff39 | 2025-08-23 | Warnings | ASCORBIC ACID |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

